๐Ÿ•ต๏ธ Nasus Pharma Ltd ($NSRX)

SEC insider & ownership activity, last 12 months ยท CIK 2029039 ยท every row links its SEC filing

Insider buy value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.

Insider flow

1 buyer, value withheld pending verification (3 lots) ยท 0 sellers, $0 (0 lots)

InsiderBuysBoughtSellsSoldLast
Teleman Dan Benjamin3value withheld pending verification 0โ€“Jun 17, 2026

5%+ holders

HolderStakeClassScheduleEvent
Udi Gilboa 21.1% 13GNov 10, 2025 filing โ†—
Dr. Dalia Megiddo 20.9% 13GNov 12, 2025 filing โ†—
Dr. Ronnie Hershman 15.3% 13GNov 13, 2025 filing โ†—
Balyasny Asset Management L.P. 10.0% 13GMay 15, 2026 filing โ†—
Balyasny Asset Management L.P. 10.0% 13GAug 14, 2026 filing โ†—
BAM GP LLC 10.0% 13GAug 14, 2026 filing โ†—
Balyasny Asset Management Holdings LP 10.0% 13GAug 14, 2026 filing โ†—
Dames GP LLC 10.0% 13GAug 14, 2026 filing โ†—
Dmitry Balyasny 10.0% 13GAug 14, 2026 filing โ†—
Hershman Holdings LLC 9.9% 13GNov 13, 2025 filing โ†—
Capital Point Ltd. 6.3% 13GAug 20, 2025 filing โ†—
Funicular Funds, LP 5.2% 13GApr 7, 2026 filing โ†—
Cable CAR Capital, LP 5.2% 13GApr 7, 2026 filing โ†—
Ma-Weaver Jacob 5.2% 13GApr 7, 2026 filing โ†—

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

No 8-K filings in the last 12 months.